-
41
Vulvar squamous cell carcinoma guidelines do not include tissue-sparing techniques as a treatment option
Published 2023-03-01Get full text
Article -
42
Sentinel lymph node biopsy for cutaneous melanoma in a real life setting: analysis of 47 cases treated at a private clinic in Brazil
Published 2021-12-01“…Objective: To present clinical and histologic data, complications and frequency of SLN involvement in CM patients diagnosed and followed at a dermatology/cutaneous oncology PC in São Paulo/Brazil, who were submitted to SLNB. …”
Get full text
Article -
43
-
44
Dermoscopic findings in a patient with multiple piloleiomyomas
Published 2012-10-01Get full text
Article -
45
Thrombotic cutaneous gangrene associated with ulcerative colitis
Published 2022-10-01Get full text
Article -
46
-
47
Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma
Published 2022-10-01Get full text
Article -
48
Treatment of cutaneous tumors with topical 5% imiquimod cream
Published 2009-01-01“…The main objective of our study was to provide data on 89 patients who used a 5% imiquimod cream for the treatment of cutaneous tumors at the Cutaneous Oncology Group of the Dermatology Department of Hospital das Clinicas from 2003 to 2008. …”
Get full text
Article -
49
-
50
Radiation therapy techniques in the treatment of skin cancer: an overview of the current status and outlook
Published 2019-11-01“…Radiation therapy (RT), with its long successful history in the management of cancer, has shown to be an effective alternative or complementary method in cutaneous oncology. Specifically, for dermatology applications, RT is very often the preferred option due to its favorable cosmetic results, besides the excellent control rate of the tumor. …”
Get full text
Article -
51
-
52
-
53
Downhill esophageal varices: a systematic review of the case reports
Published 2022-08-01Get full text
Article -
54
-
55
Immunotherapy in Melanoma: Recent Advances and Future Directions
Published 2023-02-01Get full text
Article -
56
Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic
Published 2022-10-01“…Immunotherapy with cemiplimab, a recently approved PD1 inhibitor, is an important addition to the cutaneous oncology therapeutic options that may be considered in patients with advanced disease not amenable to surgery or radiotherapy. …”
Get full text
Article -
57
-
58
Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases
Published 2023-03-01Get full text
Article -
59
-
60